The simple moving average for the last 20 days is 0.00% for BBNX stock, with a simple moving average of 0.00% for the last 200 days.
BBNX) stock’s latest price update
The stock price of Beta Bionics Inc (NASDAQ: BBNX) has surged by 39.00 when compared to previous closing price of 17.00, globenewswire.com reported 2025-01-29 that IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds to Beta Bionics from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics, are expected to be $204.0 million. In addition, the underwriters have a 30-day option to purchase up to an additional 1,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions, consisting of 475,000 shares from Beta Bionics and 1,325,000 shares from the selling stockholders named in the prospectus. Beta Bionics will not receive any proceeds from any sale of shares by the selling stockholders.
BBNX Trading at 0.00% from the 50-Day Moving Average
After a stumble in the market that brought BBNX to its low price for the period of the last 52 weeks, the company was N/A to rebound, for now settling with N/A of N/A for the given period.
During the last 5 trading sessions, BBNX rose by +7.41%, in comparison to the 20-day moving average. In addition, Beta Bionics Inc saw 0.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BBNX
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.62.
Conclusion
In summary, Beta Bionics Inc (BBNX) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”.
